With the ambition to make the PCR documents as internationally applicable as possible, and thereby avoiding unnecessary barriers to trade, the International EPD System promotes global PCR harmonisation via its market-driven PCR Partnership Programme (PPP) for programme operators and PCR developers.
ISO 14025 on EPDs recommends Programme Operators (POs) to make use of available PCRs as the preferred option to avoid unnecessary double-work and proliferation of PCRs for the same product category which will lead to market confusion and less interest of making use of EPDs.
EPD POs commit and unify under the PPP to multilaterally:
Proposition: 1 euro royalty/protection fee per EPD released/published is transferred to the owner of the original, shared PCR.
The rationale of the PPP-initiative for EPD Programme Operators is to recommend to start and maintain a close contact once original available PCRs are being used by several POs. This will lead to a lot of advantages in internal daily work by POs. Some of these advantages are described below.
Please click the below download button to read more about the PPP.